CNTX Stock: The Breast Cancer Clinical Trial Data That Has Context Therapeutics Soaring Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Context Therapeutics (CNTX) stock is rising higher on Friday thanks to results from a Phase 0 breast cancer clinical trial. The post CNTX Stock: The Breast Cancer Clinical Trial Data That Has Context Therapeutics Soaring Today appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...